Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting the Clinical Response to Omalizumab With Anti-IgE Response or Syk Expression in Basophils

NCT02023151 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02023151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting the Clinical Response to Omalizumab With Anti-IgE Response or Syk Expression in Basophils
Lead sponsor
Johns Hopkins University
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2013
Completion date
August 31, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma